
Camila Masias MD
Clotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Physician
8900 N Kendall DrMiami, FL 33176
Fax+1 305-279-7778
Overview of Dr. Masias
Dr. Camila Masias is a hematologist based in Miami, FL, specializing in clotting disorders, hematologic oncology, and myeloproliferative disorders. She completed her residency in internal medicine at the Icahn School of Medicine at Mount Sinai/Beth Israel and pursued a fellowship in hematology and medical oncology at Ohio State University Hospital. Dr. Masias also holds a Master of Public Health in clinical and translational research from The Ohio State University. She is currently employed at Baptist Health South Florida since 2019. Her experience includes dealing with thrombotic microangiopathy, thrombotic thrombocytopenic purpura, and thrombocytopenia. Dr. Masias has authored multiple publications on thrombosis and hemostasis and has received honors such as the Clinical Research Training Institute from the American Society of Hematology in 2019 and an Outstanding Clinical Care Award from The Ohio State University in 2018.
Education & Training
The Ohio State University Master of Public Health, Clinical and Translational Research , 2017 - 2019
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2015 - 2018
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2011 - 2014
Cayetano Heredia UniversityClass of 2008
Certifications & Licensure
FL State Medical License 2019 - 2028
OH State Medical License 2015 - 2021
NY State Medical License 2014 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Clinical Research Training Insitute American Society of Hematology, 2019
- Outstanding Clinical Care Award The Ohio State University, hematology and Oncology fellowship, 2018
Publications & Presentations
PubMed
- Foundations of systems-based hematology: thematic analysis of expert interviews to guide curriculums and promote growth.Richard C Godby, Jacob Cogan, Adam Cuker, David Garcia, Ming Y Lim
Blood Advances. 2026-03-24 - Evidence-based risk stratification of patients with acute pulmonary embolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Th...Rosa Talerico, Kerstin de Wit, Stefano Barco, Jose Bonorino, Corstiaan den Uil
Journal of Thrombosis and Haemostasis. 2026-03-01 - 1 citationsDevelopment and validation of risk models for hospital-acquired bleeding in medical inpatients: the Medical Inpatients Thrombosis and Hemostasis (MITH) study.Neil A Zakai, Katherine Wilkinson, Andrew D Sparks, Ryan T Packer, Nicholas S Roetker
Journal of Thrombosis and Haemostasis. 2026-02-01
Journal Articles
- The Role of ADAMTS13 Testing in the Diagnosis and Management of Thrombotic Microangiopathies and ThrombosisSpero R Cataland, Camila Masias, Blood
Authored Content
- ASH 22 Presentation Preview: Most/All Patients With Acquired (Immune) Thrombotic Thrombocytopenic Purpura Receive CaplacizumabDecember 2022
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









